Literature DB >> 11344880

Barriers to universal prenatal HIV testing in 4 US locations in 1997.

R A Royce1, E B Walter, M I Fernandez, T E Wilson, J R Ickovics, R J Simonds.   

Abstract

OBJECTIVES: We determined rates of prenatal HIV testing and investigated barriers to testing.
METHODS: We surveyed 1362 representative parturient women from 7 hospitals in 4 locations of the United States.
RESULTS: Overall, 89.9% of women reported being offered HIV testing and 69.6% reported being tested. Proportions of women not offered testing differed by location (range = 5.2%-16.3%), as did proportions not tested (range = 12.2%-54.4%). Among women who perceived that their clinicians had not recommended testing, 41.7% were tested, compared with 92.8% of women who perceived a strong recommendation (P < .05). Private insurance for prenatal care was also associated with not being tested. Women gave multiple reasons for not being tested, most commonly not being at risk, having been tested recently, and the test's not being offered or recommended, cited by 55.3%, 39.1% and 11.1% of women, respectively.
CONCLUSIONS: Although most parturient women were offered a prenatal HIV test and got tested, testing proportions did not reach national goals and differed significantly by location and payment status. Concern about testing consequences was not a major barrier. Perception of clinicians' recommendations strongly influenced testing. Changing provider practices will be essential to implementing universal prenatal HIV testing.

Entities:  

Mesh:

Year:  2001        PMID: 11344880      PMCID: PMC1446691          DOI: 10.2105/ajph.91.5.727

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  25 in total

1.  Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Authors:  N Shaffer; R Chuachoowong; P A Mock; C Bhadrakom; W Siriwasin; N L Young; T Chotpitayasunondh; S Chearskul; A Roongpisuthipong; P Chinayon; J Karon; T D Mastro; R J Simonds
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

2.  Elective cesarean delivery to reduce the transmission of HIV.

Authors:  L E Riley; M F Greene
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

3.  6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.

Authors:  F Dabis; P Msellati; N Meda; C Welffens-Ekra; B You; O Manigart; V Leroy; A Simonon; M Cartoux; P Combe; A Ouangré; R Ramon; O Ky-Zerbo; C Montcho; R Salamon; C Rouzioux; P Van de Perre; L Mandelbrot
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

4.  Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.

Authors:  S Z Wiktor; E Ekpini; J M Karon; J Nkengasong; C Maurice; S T Severin; T H Roels; M K Kouassi; E M Lackritz; I M Coulibaly; A E Greenberg
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

5.  Attitude of pregnant women towards HIV testing in Abidjan, Côte d'Ivoire and Bobo-Dioulasso, Burkina Faso. DITRAME Study Group (ANRS 049 Clinical Trial). Diminution de la Transmission Mère Enfant du VIH. Agence Nationale de Recherches sur le SIDA.

Authors:  M Cartoux; P Msellati; N Meda; C Welffens-Ekra; L Mandelbrot; V Leroy; P Van de Perre; F Dabis
Journal:  AIDS       Date:  1998-12-03       Impact factor: 4.177

6.  Compliance with voluntary prenatal HIV testing in a large health maintenance organization (HMO).

Authors:  C Limata; E J Schoen; D Cohen; S B Black; C P Quesenberry
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-06-01

7.  Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy.

Authors:  E R Myers; J W Thompson; K Simpson
Journal:  Obstet Gynecol       Date:  1998-02       Impact factor: 7.661

8.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Authors:  L A Guay; P Musoke; T Fleming; D Bagenda; M Allen; C Nakabiito; J Sherman; P Bakaki; C Ducar; M Deseyve; L Emel; M Mirochnick; M G Fowler; L Mofenson; P Miotti; K Dransfield; D Bray; F Mmiro; J B Jackson
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

9.  International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV.

Authors:  V Leroy; M L Newell; F Dabis; C Peckham; P Van de Perre; M Bulterys; C Kind; R J Simonds; S Wiktor; P Msellati
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

10.  Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.

Authors:  N A Wade; G S Birkhead; B L Warren; T T Charbonneau; P T French; L Wang; J B Baum; J M Tesoriero; R Savicki
Journal:  N Engl J Med       Date:  1998-11-12       Impact factor: 91.245

View more
  14 in total

1.  An analysis of the serostatus approach to fighting the HIV epidemic.

Authors:  Joseph N Inungu
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

Review 2.  Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned?

Authors:  L J Yee; S D Rhodes
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

3.  Promising strategies for preventing perinatal HIV transmission: model programs from three states.

Authors:  Jill Clark; Stephanie Sansom; B Joyce Simpson; Frances Walker; Cheryl Wheeler; Kelly Yazdani; Amy Zapata
Journal:  Matern Child Health J       Date:  2006-06-03

4.  Trends in prenatal discussion and HIV testing, 1996-2001: Pregnancy Risk Assessment Monitoring System.

Authors:  Amy Lansky; Stephanie L Sansom; Leslie L Harrison; Tonya Stancil
Journal:  Matern Child Health J       Date:  2007-03-06

5.  Disparities in prenatal HIV testing: evidence for improving implementation of CDC screening guidelines.

Authors:  Deborah N Pearlman; Abigail R Averbach; Sally Zierler; Kevin Cranston
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

6.  Violence during pregnancy among women with or at risk for HIV infection.

Authors:  Linda J Koenig; Daniel J Whitaker; Rachel A Royce; Tracey E Wilson; Michelle R Callahan; M Isabel Fernandez
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

7.  HIV status determination among tuberculosis patients from California during 2008.

Authors:  Darryl G Kong; James P Watt; Suzanne Marks; Jennifer Flood
Journal:  J Public Health Manag Pract       Date:  2013 Mar-Apr

8.  Voluntary HIV counseling and testing of pregnant women--an assessment of compliance with Michigan public health statutes.

Authors:  Paula Schuman; Theodore B Jones; Suzanne Ohmit; Cynthia Marbury; Marilyn P Laken
Journal:  MedGenMed       Date:  2004-06-16

9.  Correlates of prenatal HIV testing in women with undocumented status at delivery.

Authors:  Mayris P Webber; Penelope Demas; Nancy Blaney; Mardge H Cohen; Rosalind Carter; Margaret Lampe; Denise Jamieson; Robert Maupin; Steven Nesheim; Marc Bulterys
Journal:  Matern Child Health J       Date:  2007-10-30

10.  Factors associated with declining a rapid human immunodeficiency virus test in labor and delivery.

Authors:  Kathrine R Tan; Margaret A Lampe; Susan P Danner; Patricia Kissinger; Mayris P Webber; Mardge H Cohen; Mary Jo O'Sullivan; Steven Nesheim; Denise J Jamieson
Journal:  Matern Child Health J       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.